Anticipated Completion of Acquisition of BHI

12th January 2006 ANTICIPATED COMPLETION OF ACQUISITION OF BOOTS HEALTHCARE INTERNATIONAL Reckitt Benckiser plc (RB.L) today announced that the proposed acquisition of Boots Healthcare International (BHI) is anticipated to complete at the end of January 2006. The EU competition authority gave unconditional clearance to the proposed acquisition last week (announced on Friday 6th January). This follows similar clearances in the USA and Australia amongst other jurisdictions. For Further Information Reckitt Benckiser plc Tel +44 (0) 1753 217 800 Tom Corran, SVP Investor Relations & Corporate Communications (all calls) Fiona Fong Head of Corporate Communications (press calls) Mark Wilson Corporate Controller & Investor Relations Manager (investor calls) Tim Spratt Financial Dynamics telephone +44 (0) 207 831 3113 Notes for Editors Reckitt Benckiser is the world leader in household cleaning, excluding laundry, and has a major presence in health and personal care. The Company is truly global, with over 60 operating companies and over 40 manufacturing facilities worldwide and has sales in 180 countries. The Company employs 20,000 people around the world. Amongst the Company's leading brands in household are Lysol, the world leader in disinfecting cleaning, Calgonit & Finish & Electrasol, the world leaders in automatic dishwashing, Woolite, world leader in fine fabrics, Vanish & Spray'nWash, world leaders in fabric treatment, Airwick and Mortein, both No.2 brands in air care and pest control respectively. In Health & Personal Care (15% of net revenues), leading brand positions include Veet, the world number one depilatory and Dettol the world's leading antiseptic, Gaviscon the No.1 gastro intestinal remedy in UK and Lemsip the UK no.1. in cold/flu remedies. Reckitt Benckiser is headquartered in Slough just outside London and is listed on the London stock exchange. With a market capitalization of c.£12.5bn it ranks among the top 30 UK listed companies. Reckitt Benckiser had net revenues of £3.87bn, operating profit of £770m, and net income of £586m in 2004. D
UK 100

Latest directors dealings